OpenFilings
Damora Therapeutics, Inc.
Form
8-K
Report Period
2025-12-31
Date Filed
2026-01-06
Time Filed
08:15:25
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EX-4.1
EX-10.1
Filing on SEC Edgar